Richard Kim, MD - Enhancing Treatment Sequencing to Extend Survival: Tailoring Later-Line Care to the Patient With Metastatic Colorectal Cancer
Please visit answersincme.com/TSH860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the management of metastatic colorectal cancer (mCRC) discuss sequencing strategies to enhance patient quality of life during late...
Therapeutic Advances Across GI Cancers: Highlights From GI25
Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC, neoadjuvant approaches in esophageal cancer, and innovative studies on ctDNA.
TRANSCRIPT
Dr. Shaalan Beg: Hello and welcome to the ASCO...
Episode 35: Kai Wright and Lizzie Ratner’s The Plague in the Shadows
Journalists Kai Wright and Lizzy Ratner talk with The City editor-in-chief Richard Kim about their Blindspot podcast digging into the early years of the HIV/AIDS epidemic and focusing on overlooked populations including intravenous drug users, incarcerated people, and the pediatric patients separ...
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
Please visit answersincme.com/TNM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Richard Kim, MD. In this activity, an expert in oncology discusses when and how to sequence later-line and chemotherapy-free therapies in meta...
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
Please visit answersincme.com/TNM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Richard Kim, MD. In this activity, an expert in oncology discusses when and how to sequence later-line and chemotherapy-free therapies in meta...
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
Please visit answersincme.com/TNM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Richard Kim, MD. In this activity, an expert in oncology discusses when and how to sequence later-line and chemotherapy-free therapies in meta...
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
Please visit answersincme.com/TNM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Richard Kim, MD. In this activity, an expert in oncology discusses when and how to sequence later-line and chemotherapy-free therapies in meta...
Structures and Tax Considerations from an Attorney's Perspective
In this episode, we sit down with Chris Chan of ZC Settlements at Ringler and Richard Kim, principal attorney at the Law Offices of Richard Kim. We talk about how taxes and government benefits can have a major impact on the final outcome of a case, we look at how those considerations come into p...
On Catholic Imagination, Part 10: I Have Called You Friends
Episode Topic: I Have Called You FriendsEver felt your imagination crave a deeper sense of wonder? Step directly into a rich world where mythic landscapes awaken your soul and ancient faith reshapes everyday life. By reconnecting truth with beauty, this immersive experience rekindles your spirit,...
Sam Englebardt and Richard Kim - Investing in Immersive Worlds - [Invest Like the Best, EP. 259]
![Sam Englebardt and Richard Kim - Investing in Immersive Worlds - [Invest Like the Best, EP. 259]](https://cdn-images-3.listennotes.com/podcasts/invest-like-the/sam-englebardt-and-richard-ehsaxC7Buz--HF8poXQsrMw.300x300.jpg)
Today, my guests are Sam Englebardt and Richard Kim, general partners at venture fund, Galaxy Interactive. Having come from the media and finance sectors, respectively, Sam and Richard joined forces in 2018 to invest in their shared thesis that immersive digital experiences would become the domin...
